| pubmed-article:10338904 | pubmed:abstractText | To evaluate the efficacy, safety, and impact on asthma-specific quality of life of salmeterol, a highly selective, long-acting beta 2-agonist, compared with that of placebo (i.e., "as-needed" albuterol). | lld:pubmed |
